| Financial Year |
March 31 2023 |
| Monetary Funds |
219,601,702.81 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
6,563,837.69 |
| Accounts Receivable |
119,706,746.67 |
| Advances to Suppliers |
21,307,265.71 |
| Other Receivables |
20,780,581.53 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
183,129,946.95 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
18,973,912.71 |
| Total Current Assets |
605,692,247.91 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
76,537,609.11 |
| Fixed Assetes |
349,805,349.15 |
| Under-construction Projects |
313,414,396.11 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
34,691,435.39 |
| R&D expenses |
15,342,416.06 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
13,451,386.79 |
| Deferred Income Tax Assets |
69,586,946.21 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
935,478,909.25 |
| Total Assets |
1,541,171,157.16 |
| Short-Term Loans |
65,154,248.91 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
52,041,502.20 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
11,634,115.95 |
| Taxes Payable |
4,544,419.15 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
14,547,876.16 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
41,372,719.45 |
| Other Current Liabilities |
5,212,919.50 |
| Sub-Total of Current Liabilities |
234,607,182.11 |
| Long-term Loans |
156,400,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
3,825,818.12 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
218,089,181.83 |
| Total Liabilities |
452,696,363.94 |
| Paid-In Capital(Or Share Stock) |
247,806,170.00 |
| Capital Surplus |
641,827,191.20 |
| Surplus Reserve |
73,841,867.35 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
124,837,337.18 |
| Minority Stockholder's Interest |
287,339.77 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,088,187,453.45 |
| Owner's Equity（Stockholder's Equity） |
1,088,474,793.22 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,541,171,157.16 |
